Abstract
The term “rhabdomyolysis” defines a clinical and biological syndrome, potentially life-threatening, that occurs after the lysis of skeletal striated muscle fibers whose contents are released into the general circulation. The development of rhabdomyolysis can be associated with a wide variety of diseases, injuries, drugs, toxins and various viral infections.
Recently, SARS-coV-2 has been reported as the cause of rhabdomyolysis, especially in those with severe forms of COVID-19. Very few cases describe the occurrence of this syndrome in patients with moderate forms of the disease.
We will present the case of a patient with a mild to moderate form of the SARS-CoV-2 infection in contrast to the rhabdomyolysis syndrome, and also the lack of kidney damage.